1. Home
  2. ASYS vs QNCX Comparison

ASYS vs QNCX Comparison

Compare ASYS & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amtech Systems Inc.

ASYS

Amtech Systems Inc.

HOLD

Current Price

$12.98

Market Cap

164.5M

Sector

Technology

ML Signal

HOLD

Logo Quince Therapeutics Inc.

QNCX

Quince Therapeutics Inc.

HOLD

Current Price

$0.11

Market Cap

167.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASYS
QNCX
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
167.0M
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
ASYS
QNCX
Price
$12.98
$0.11
Analyst Decision
Hold
Analyst Count
0
3
Target Price
N/A
$10.00
AVG Volume (30 Days)
171.8K
33.4M
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$79,364,000.00
N/A
Revenue This Year
$2.82
N/A
Revenue Next Year
$18.75
N/A
P/E Ratio
$1,278.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.20
$0.09
52 Week High
$18.59
$4.55

Technical Indicators

Market Signals
Indicator
ASYS
QNCX
Relative Strength Index (RSI) 48.02 27.86
Support Level $11.60 $0.09
Resistance Level $13.26 $0.98
Average True Range (ATR) 0.79 0.01
MACD 0.06 0.09
Stochastic Oscillator 47.20 18.57

Price Performance

Historical Comparison
ASYS
QNCX

About ASYS Amtech Systems Inc.

Amtech Systems Inc provides equipment, consumables and services for semiconductor device packaging, wafer production and device fabrication. Its products are used to fabricate and package GPUs for AI applications, SiC and Si power devices, and other optical, analog and digital devices, and are sold to semiconductor packaging, electronic assembly and device fabrication companies. It operates through two segments: Thermal Processing Solutions, which includes conveyorized reflow equipment, high-temperature conveyorized furnaces and diffusion furnaces with maximum revenue; and Semiconductor Fabrication Solutions, which includes consumables, equipment and services for wafer polishing, dicing and cleaning. The majority of revenue is derived from the United States.

About QNCX Quince Therapeutics Inc.

Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.

Share on Social Networks: